Evaluation of stat orders in a teaching hospital: A chart review

Clinical Drug Investigation

Volumn 31, Issue 4, 2011, Pages 231-235

  Fahimi, Fanak ^a,b   Sahraee, Zahra ^a   Amini, Shahideh ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug utilisation; Prescribing

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; GRANISETRON; HYDROCORTISONE; MORPHINE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG USE; DYSPNEA; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ORDER; MEDICAL RECORD REVIEW; PREOPERATIVE TREATMENT; PRESCRIPTION; PRIORITY JOURNAL; STAT ORDER; TEACHING HOSPITAL; VOMITING; WARD;

ADULT; AGED; DRUG PRESCRIPTIONS; HOSPITALS, TEACHING; HUMANS; MEDICATION SYSTEMS, HOSPITAL; MIDDLE AGED;

EID: 79952384293     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11540000-000000000-00000     Document Type: Article

References (37)

1. Jaffe A, Levine J, Citrome L. Stat medication administration predicts hospital discharge. Psychiatr Q 2009; 80: 65-73
2. Kuske B, Wallin T, Mansour AN. Priority-based hospital order system reduces percentage of "STAT" orders and enhances response time especially for clinical results. Swedish Medical Center [online]. Available from URL: http://www.innovations.ahrq.gov/content.aspx?id=20702007 [Accessed 2010 Nov 19]
3. Ambwani S, Mathur AK. Rational drug use. Health Administrator 2006; 19: 5-7
4. Anderson J, Adams CD, Antam EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Circulation 2007; 116: e148-304
5. Henzi I, Walder B, Martin R. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90: 186-94 (Pubitemid 30022994)
6. Ioannidis PA, Hesketh PJ, Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol 2000; 18: 3409-22
7. Feeney K, Cain M, Nowak AK. Chemotherapy induced nausea and vomiting prevention and treatment. Aust Fam Physician 2007; 36: 702-6
8. DiVall MV, Cersosimo RJ. Prevention and treatment of chemotherapy-induced nausea and vomiting: a review. Formulary 2007; 42: 378-88 (Pubitemid 47020499)
9. Hesketh PJ. Evidence-based prevention of CINV: what's new in ASCO guidelines. Supportive Oncology 2008; 6: 71-2 (Pubitemid 351297971)
10. Domino KB, Anderson EA. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a metaanalysis. Anesth Analg 1999; 88: 1370-9 (Pubitemid 29246955)
11. Zoorob RJ, Campbell JS. Acute dyspnea in the office. Am Fam Physician 2003; 68: 1803-10 (Pubitemid 37385774)
12. Karnani NJ, Reisfield M, Wilson GR. Evaluation of chronic dyspnea. Am Fam Physician 2005; 71: 1529-37, 1538 (Pubitemid 40563082)
13. Adams KF, Stevenson LW, Wagoner LE, et al. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Cardiac Failure 2006; 12: 10-38 (Pubitemid 43267749)
14. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2008; 29: 2388-442
15. Hunter MH, King DE. COPD: management of acute exacerbations and chronic stable disease. Am Fam Physician 2001; 64: 603-12, 621-2
16. Rodríguez RR. COPD exacerbations management. Thorax 2006; 61: 535-44
17. Hurst JR, Wedzicha JA. Management and prevention of chronic obstructive pulmonary disease exacerbations a state of the art review. BMC Med 2009; 7: 40, doi: 10.1186/1741-7015-7-40. Epub
18. De Jong YP. Oral or IV prednisolone in the treatment of COPD exacerbations. Chest 2007; 132: 1741-7
19. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD. Chest 2008; 133: 756-66
20. Johnson MK, Stevenson RD. Management of an acute exacerbation of COPD: are we ignoring the evidence. Thorax 2005; 57 Suppl. II: ii15-23
21. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-80 (Pubitemid 41829947)
22. Mandell LM. Thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: S27-72
23. Campbell Jr GD. Commentary on the 1993 American thoracic society guidelines for the treatment of communityacquired pneumonia. Chest 1999; 115: 14S-18S (Pubitemid 29133431)
24. Schouten JA. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med 2005; 63: 323-35
25. Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 2006; 24 (18): 1-16
26. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. May 2008, Revised June 2009. SIGN: Scottish Intercollegiate Guidelines Network. NHS Quality Improvement Scotland [online].Available fromURL: http://www.sign.ac.uk/pdf/sign101.pdf [Accessed 2010 Nov 1]
27. Bateman ED, Bousquet J, Clark T, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-78
28. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2000; 102: 1193-209
29. Fraker TD, Fihn SD. Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina. Circulation 2007; 116: 2762-72
30. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008; 133 (6 Suppl.): 454S-545S (Pubitemid 351892971)
31. Pitimana-aree S, Forrest D, Brown G, et al. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med 1998; 24: 217-23 (Pubitemid 28190812)
32. Brett S. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness. Critical Care 2005; 9: 45-50 (Pubitemid 40246770)
33. Middleton PM. Epistaxis. Emerg Med Australas 2004; 16: 428-40 (Pubitemid 39551184)
34. Melia L, McGarry G. Epistaxis in adults: a clinical review. Br J Hosp Med 2008; 69: 404-7
35. Laupland KB. Fever in the critically ill medical patient. Crit Care Med 2009; 37: S273-S278
36. Holloman LC, Marder SR. Management of acute extrapyramidal effects induced by antipsychotic drugs. Am J Health-Syst Pharm 1997; 54: 2461-77
37. Frank E, Liu J, Kinasewitz G, et al. Multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clin Ther 2002; 24: 1292-308 (Pubitemid 35026153)